Year: 1995
Type: article
Abstract: To the Editor: Tugwell et al. ( July 20 issue) 1 found that "patients with severe rheumatoid arthritis and only partial responses to methotrexate had clinically important improvement after combination therapy with cyclosporine and methotrexate."We are concerned about the manner in which the cyclosporine doses were adjusted.No mention of the patients' serum cyclosporine levels was made.Determination of serum cyclosporine levels might have allowed a better understanding of the results with respect to therapeutic serum ranges of this medication.The authors state that people with rheumatoid arthritis "have a risk of cancer 20 to 30 times higher than people in general."Cash and Klippel 2 concluded in a 1995 review that patients with rheumatoid arthritis are not at increased risk of cancer overall, although the rates of selected cancers, such as hematologic cancers, especially multiple myeloma and non-Hodgkin's lymphoma, appear to be increased.
Source: New England Journal of Medicine
Authors: Christopher G. Acker, Arthur Greenberg
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W2076116711
